| Abbott Laboratories (NYSE:ABT) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $143.00 price target on the stock. This represents a 5.1% upside from the current price of $136.01. |
| Beta Bionics (NASDAQ:BBNX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $26.00 price target on the stock. This represents a 36.2% upside from the current price of $19.09. |
| Boston Scientific (NYSE:BSX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $118.00 price target on the stock. This represents a 16.1% upside from the current price of $101.60. |
| Conagra Brands (NYSE:CAG) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $22.00 price target on the stock. This represents a 1.9% upside from the current price of $21.59. |
| Janover (NASDAQ:DFDV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $45.00 price target on the stock. This represents a 57.5% upside from the current price of $28.57. |
| DexCom (NASDAQ:DXCM) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $102.00 price target on the stock. This represents a 22.8% upside from the current price of $83.05. |
| Enliven Therapeutics (NASDAQ:ELVN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $37.00 price target on the stock. This represents a 59.1% upside from the current price of $23.25. |
| Freshpet (NASDAQ:FRPT) is now covered by analysts at UBS Group AG. They set a "sell" rating and a $65.00 price target on the stock. This represents a 11.9% downside from the current price of $73.76. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $42.00 price target on the stock. This represents a 13.8% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $50.00 price target on the stock. This represents a 35.4% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $46.00 price target on the stock. This represents a 24.6% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $41.00 price target on the stock. This represents a 11.1% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Raymond James. They set an "outperform" rating and a $45.00 price target on the stock. This represents a 21.9% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $45.00 price target on the stock. This represents a 21.9% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $48.00 price target on the stock. This represents a 30.0% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $48.00 price target on the stock. This represents a 30.0% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $52.00 price target on the stock. This represents a 40.8% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $45.00 price target on the stock. This represents a 21.9% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $47.00 price target on the stock. This represents a 27.3% upside from the current price of $36.92. |
| Hinge Health (NYSE:HNGE) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $43.00 price target on the stock. This represents a 16.5% upside from the current price of $36.92. |
| Inogen (NASDAQ:INGN) is now covered by analysts at B. Riley. They set a "buy" rating and a $14.00 price target on the stock. This represents a 106.5% upside from the current price of $6.78. |
| Knife River (NYSE:KNF) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $129.00 price target on the stock. This represents a 55.2% upside from the current price of $83.14. |
| Medtronic (NYSE:MDT) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $110.00 price target on the stock. This represents a 24.6% upside from the current price of $88.25. |
| McCormick & Company, Incorporated (NYSE:MKC) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $83.00 price target on the stock. This represents a 11.8% upside from the current price of $74.22. |
| Martin Marietta Materials (NYSE:MLM) is now covered by analysts at Royal Bank of Canada. They set a "sector perform" rating and a $515.00 price target on the stock. This represents a 4.8% downside from the current price of $541.19. |
| MNTN (NYSE:MNTN) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $23.00 price target on the stock. This represents a 17.0% upside from the current price of $19.66. |
| MNTN (NYSE:MNTN) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $27.00 price target on the stock. This represents a 37.4% upside from the current price of $19.66. |
| MNTN (NYSE:MNTN) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $20.00 price target on the stock. This represents a 1.8% upside from the current price of $19.66. |
| MNTN (NYSE:MNTN) is now covered by analysts at Susquehanna. They set a "positive" rating and a $38.00 price target on the stock. This represents a 93.3% upside from the current price of $19.66. |
| MNTN (NYSE:MNTN) is now covered by analysts at Raymond James. They set an "outperform" rating and a $27.00 price target on the stock. This represents a 37.4% upside from the current price of $19.66. |
| MNTN (NYSE:MNTN) is now covered by analysts at Loop Capital. They set a "buy" rating and a $29.00 price target on the stock. This represents a 47.5% upside from the current price of $19.66. |
| MNTN (NYSE:MNTN) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $22.00 price target on the stock. This represents a 11.9% upside from the current price of $19.66. |
| MNTN (NYSE:MNTN) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $25.00 price target on the stock. This represents a 27.2% upside from the current price of $19.66. |
| Procore Technologies (NYSE:PCOR) is now covered by analysts at Arete. They set a "buy" rating and a $91.00 price target on the stock. This represents a 39.7% upside from the current price of $65.15. |
| Insulet (NASDAQ:PODD) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $365.00 price target on the stock. This represents a 18.7% upside from the current price of $307.59. |
| Sweetgreen (NYSE:SG) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $19.00 price target on the stock. This represents a 44.7% upside from the current price of $13.13. |
| Signet Jewelers (NYSE:SIG) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $102.00 price target on the stock. This represents a 29.7% upside from the current price of $78.64. |
| Talos Energy (NYSE:TALO) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $14.00 price target on the stock. This represents a 50.1% upside from the current price of $9.33. |
| Tandem Diabetes Care (NASDAQ:TNDM) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $24.00 price target on the stock. This represents a 16.1% upside from the current price of $20.67. |
| ZenaTech (NASDAQ:ZENA) is now covered by analysts at Maxim Group. They set a "buy" rating and a $9.00 price target on the stock. This represents a 73.6% upside from the current price of $5.18. |
